# An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women

> **NCT04330989** · NA · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 300 (actual)

## Conditions studied

- HIV-1-infection
- Antenatal Care

## Interventions

- **BEHAVIORAL:** iNSC and Adherence supporter training

## Key facts

- **NCT ID:** NCT04330989
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2022-02-10
- **Final completion:** 2022-02-10
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2023-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04330989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04330989, "An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04330989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*